Abstract | BACKGROUND: METHODS: RESULTS: All five patients had relief of the carcinoid syndrome after treatment. In four of the five patients, the relief was prolonged (>3 months); in one patient, the relief of symptoms was transient (2 months). Four of five patients had a transient reduction in hormonal tumor markers (the fifth patient did not have hormonal-level follow-up). During a follow-up period of 2.5 years, four of the five patients died. The 6-month survival rate was 80%, the 1-year survival rate was 60%, the 2-year survival rate was 40%, and the 2.5-year survival was 20%. One patient is alive 30 months after treatment. CONCLUSION: Hepatic cryotherapy can provide symptomatic relief for patients with hepatic metastates producing the carcinoid syndrome.
|
Authors | R S Shapiro, M Shafir, M Sung, R Warner, N Glajchen |
Journal | Abdominal imaging
(Abdom Imaging)
1998 May-Jun
Vol. 23
Issue 3
Pg. 314-7
ISSN: 0942-8925 [Print] United States |
PMID | 9569305
(Publication Type: Comparative Study, Journal Article)
|
Topics |
- Aged
- Carcinoid Tumor
(diagnosis, secondary, therapy)
- Cryotherapy
- Female
- Follow-Up Studies
- Humans
- Liver Neoplasms
(diagnosis, secondary, therapy)
- Malignant Carcinoid Syndrome
(mortality)
- Middle Aged
- Survival Rate
- Tomography, X-Ray Computed
|